Rockefeller President and CEO Commits Suicide?

James S. McDonald, president and chief executive of investment management firm Rockefeller & Co., has died of an apparently self-inflicted gunshot wound, Massachusetts authorities said Tuesday.

McDonald, 56, was found in his vehicle at about 3 p.m. Sunday behind a car dealership in Dartmouth, about 50 miles south of Boston, said Gregg Miliote, a spokesman for the Bristol district attorney's office.

Read more...

Libyan Whose 'Confession' Facilitated Iraq War Found Dead

The United States says it is probing into the suspected suicide of a former Guantanamo detainee and alleged al-Qaeda operative in a Libyan prison.

Ali Mohammed al-Fakheri, alias Ibn al-Sheikh al-Libi, 46, who was jailed for life in Libya after his transfer from US custody in 2006, is said to have committed suicide, but there has been no mention of when he is supposed to have taken his own life.

Read more...

The GM Genocide: Thousands Of Indian Farmers Are Committing Suicide After Using Genetically Modified Crops

Shankara, like millions of other Indian farmers, had been promised previously unheard of harvests and income if he switched from farming with traditional seeds to planting GM seeds instead.

Beguiled by the promise of future riches, he borrowed money in order to buy the GM seeds. But when the harvests failed, he was left with spiralling debts - and no income.
So Shankara became one of an estimated 125,000 farmers to take their own life as a result of the ruthless drive to use India as a testing ground for genetically modified crops.
The crisis, branded the 'GM Genocide' by campaigners, was highlighted recently when Prince Charles claimed that the issue of GM had become a 'global moral question' - and the time had come to end its unstoppable march.

Read more...

Slimmers Warned: EU Suspends Weight-loss Drug Licence Because 'Psychiatric Risks Outweigh Benefits'

Safety chiefs have suspended the use of a weight loss drug over concerns that it may be linked to suicide and sudden death.
Officials said the risk of side effects from the drug, Acomplia, outweighed its benefits.
Almost 100,000 Britons have used the drug since its launch two years ago, when it was hailed as a £2 a day wonder pill.

However, seven deaths, including a suicide, have been associated with the anti-obesity treatment, which also doubles the risk of psychiatric disorders.
Around 2,500 adverse reactions have been reported by British patients since it became available to private buyers two years ago. U.S. authorities refused to approve the drug amid mounting scientific evidence of the suicide dangers.
But just four months ago Acomplia was cleared to be used as a 'last-chance' solution on the NHS by the Government's rationing body, the National Institute for Health and Clinical Excellence.

Read more...